A middle-aged, hypertensive, dyslipidemia T2DM patient on insulin therapy visited the clinic with an inadequately controlled glycemic profile along with progressive weight gain. What would have been the next step when the patient presented with inadequately controlled glycemia in this case study? Listen to the expert.